Charles Ayemoba
Staff Research Associate
University of California San Francisco




Charles Ayemoba was previously a Pre-Doctoral Trainee of Biomedical Research Technologies at Boston University School of Medicine. He is now a Staff Research Associate at the University of California, San Francisco. Charles graduated from the University of Illinois at Urbana-Champaign with a bachelors degree in Molecular and Cellular Biology, and then went on to attend Boston University School of Medicine and received a Masters in Biotechnology.

Pre-Doctoral Trainee (previously held)
Boston University School of Medicine, Graduate Medical Sciences
Biomedical Research Technologies


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Shi Y, Dincheva-Vogel L, Ayemoba CE, Fung JP, Bergamaschi C, Pavlakis GN, Farzaneh F, Gaensler KML. IL-15/IL-15Ra/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice. Blood Adv. 2018 Nov 27; 2(22):3177-3192. PMID: 30482760.
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 1 publications over 1 distinct years, with a maximum of 1 publications in 2018

YearPublications
20181
Contact for Mentoring: